The landscape of obesity treatment is undergoing a transformation with the emergence of several novel injectable therapies. Semaglutide's cousin , Cagrilintide , a GLP-1/GIP/GCG triple agonist , and AOD-9604 https://nexaphresearchpeptides.com/product-category/growth-hormone-peptides/